Spots Global Cancer Trial Database for stage iiia colorectal cancer

Every month we try and update this database with for stage iiia colorectal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer	NCT03095781	Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa...	XL888 Pembrolizumab	18 Years -	Emory University
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin	NCT02677389	Cancer Survivor Healthy Subject Stage I Colorec... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIA Color... Stage IIB Breas... Stage IIB Color... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIB Brea... Stage IIIB Colo... Stage IIIC Brea... Stage IIIC Colo...	Educational Int... Internet-Based ... Monitoring Devi... Quality-of-Life... Questionnaire A...	30 Years - 75 Years	University of Wisconsin, Madison
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin	NCT02677389	Cancer Survivor Healthy Subject Stage I Colorec... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIA Color... Stage IIB Breas... Stage IIB Color... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIB Brea... Stage IIIB Colo... Stage IIIC Brea... Stage IIIC Colo...	Educational Int... Internet-Based ... Monitoring Devi... Quality-of-Life... Questionnaire A...	30 Years - 75 Years	University of Wisconsin, Madison
Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer	NCT04044430	Metastatic Colo... Metastatic Colo... Metastatic Micr... Metastatic Rect... Stage III Colon... Stage III Color... Stage III Recta... Stage IIIA Colo... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Colo... Stage IIIC Rect... Stage IV Colon ... Stage IV Colore... Stage IV Rectal... Stage IVA Colon... Stage IVA Color... Stage IVA Recta... Stage IVB Colon... Stage IVB Color... Stage IVB Recta... Stage IVC Colon... Stage IVC Color... Stage IVC Recta...	Binimetinib Encorafenib Nivolumab Questionnaire A...	18 Years -	University of California, San Francisco
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer	NCT03095781	Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa...	XL888 Pembrolizumab	18 Years -	Emory University
Programs To Support You During Chemotherapy	NCT02489422	Depression Fatigue Stage IIA Color... Stage IIB Color... Stage IIC Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IVA Color... Stage IVB Color... Pancreatic Canc... Esophageal Canc... Appendix Cancer Stomach Cancer Gallbladder Can... Liver Cancer Small Intestine... Large Intestine... Anal Cancer Biliary Tract C... Gastrointestina...	Laboratory Biom... Questionnaire A... Daily Survey Ad... Yoga Skills Tra... Attention Contr... Actigraphy Asse...	21 Years -	Wake Forest University Health Sciences
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery	NCT02511821	Stage I Adult L... Stage I Colorec... Stage IA Gastri... Stage IA Pancre... Stage IB Gastri... Stage IB Pancre... Stage II Adult ... Stage IIA Color... Stage IIA Gastr... Stage IIA Pancr... Stage IIB Color... Stage IIB Gastr... Stage IIB Pancr... Stage IIC Color... Stage III Pancr... Stage IIIA Adul... Stage IIIA Colo... Stage IIIA Gast... Stage IIIB Adul... Stage IIIB Colo... Stage IIIB Gast... Stage IIIC Adul... Stage IIIC Colo... Stage IIIC Gast... Stage IV Gastri... Stage IVA Color... Stage IVA Liver... Stage IVA Pancr... Stage IVB Color... Stage IVB Liver... Stage IVB Pancr...	Computer-Assist... Vivofit watch Quality-of-Life... Questionnaire A...	21 Years -	City of Hope Medical Center
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)	NCT02728596	Febrile Neutrop... Stage 0 Breast ... Stage 0 Colorec... Stage 0 Non-Sma... Stage I Colorec... Stage IA Breast... Stage IA Non-Sm... Stage IB Breast... Stage IB Non-Sm... Stage IIA Breas... Stage IIA Color... Stage IIA Non-S... Stage IIB Breas... Stage IIB Color... Stage IIB Non-S... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIC Brea... Stage IIIC Colo... Stage IV Breast... Stage IV Non-Sm... Stage IVA Color... Stage IVB Color...	Preventive Inte... Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners	NCT03112668	Malignant Femal... Malignant Hepat... Partner Stage III Breas... Stage III Cervi... Stage III Color... Stage III Lung ... Stage III Prost... Stage III Skin ... Stage III Uteri... Stage IIIA Brea... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Lung... Stage IIIA Skin... Stage IIIA Uter... Stage IIIB Brea... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Lung... Stage IIIB Skin... Stage IIIB Uter... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Skin... Stage IIIC Uter... Stage IV Breast... Stage IV Cervic... Stage IV Colore... Stage IV Lung C... Stage IV Prosta... Stage IV Skin M... Stage IV Uterin... Stage IVA Cervi... Stage IVA Color... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Color... Stage IVB Uteri...	Cognitive Behav... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
Programs To Support You During Chemotherapy	NCT02489422	Depression Fatigue Stage IIA Color... Stage IIB Color... Stage IIC Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IVA Color... Stage IVB Color... Pancreatic Canc... Esophageal Canc... Appendix Cancer Stomach Cancer Gallbladder Can... Liver Cancer Small Intestine... Large Intestine... Anal Cancer Biliary Tract C... Gastrointestina...	Laboratory Biom... Questionnaire A... Daily Survey Ad... Yoga Skills Tra... Attention Contr... Actigraphy Asse...	21 Years -	Wake Forest University Health Sciences
Programs To Support You During Chemotherapy	NCT02489422	Depression Fatigue Stage IIA Color... Stage IIB Color... Stage IIC Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IVA Color... Stage IVB Color... Pancreatic Canc... Esophageal Canc... Appendix Cancer Stomach Cancer Gallbladder Can... Liver Cancer Small Intestine... Large Intestine... Anal Cancer Biliary Tract C... Gastrointestina...	Laboratory Biom... Questionnaire A... Daily Survey Ad... Yoga Skills Tra... Attention Contr... Actigraphy Asse...	21 Years -	Wake Forest University Health Sciences
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)	NCT02728596	Febrile Neutrop... Stage 0 Breast ... Stage 0 Colorec... Stage 0 Non-Sma... Stage I Colorec... Stage IA Breast... Stage IA Non-Sm... Stage IB Breast... Stage IB Non-Sm... Stage IIA Breas... Stage IIA Color... Stage IIA Non-S... Stage IIB Breas... Stage IIB Color... Stage IIB Non-S... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIC Brea... Stage IIIC Colo... Stage IV Breast... Stage IV Non-Sm... Stage IVA Color... Stage IVB Color...	Preventive Inte... Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer	NCT03095781	Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa...	XL888 Pembrolizumab	18 Years -	Emory University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: